Related Experiment Video
Updated: Jul 5, 2025
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
Effect of sublingual immunotherapy on clinical and laboratory autoimmunity
Andrzej Bozek1, Szymon Mućka1, Martyna Miodonska1
1Clinical Department of Internal Diseases, Dermatology & Allergology, Medical University of Silesia, Katowice, Poland.
Abstract:
Background: There still are few data on the long-term safety of sublingual immunotherapy (SLIT). The aim of this study was to assess the appearance of autoimmune diseases in patients before and after SLIT. Materials & methods: New cases of autoimmune diseases were monitored. Patients in the SLIT group (n = 816) were compared with controls (n = 1096). Results: The new incidences of autoimmune diseases in the SLIT group were lower compared with the control group: 18 (2.2%) versus 58 (5.3%); p < 0.05. Systemic lupus erythematosus, psoriasis and Hashimoto appeared much more often in the control group. Conclusion: SLIT had no significant effect on the induction of autoimmune diseases.
